Sandoz Group AG (SWX:SDZ)
Switzerland · Delayed Price · Currency is CHF 44.93
-0.06 (-0.13%)
Jul 17, 2025, 5:41 PM CET
Sandoz Group AG Employees
Sandoz Group AG had 22,049 employees as of December 31, 2024. The number of employees decreased by 584 or -2.58% compared to the previous year.
Employees
22,049
Change (1Y)
-584
Growth (1Y)
-2.58%
Revenue / Employee
426.77K CHF
Profits / Employee
n/a
Market Cap
19.38B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 22,049 | -584 | -2.58% |
| Dec 31, 2023 | 22,633 | 895 | 4.12% |
| Dec 31, 2022 | 21,738 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Roche Holding AG | 103,249 |
| Novartis AG | 75,883 |
| Lonza Group AG | 18,944 |
| Alcon | 25,599 |
| Galderma Group AG | 6,545 |
| Straumann Holding AG | 11,815 |
| Sonova Holding AG | 18,366 |
| Ypsomed Holding AG | 2,644 |
Sandoz Group AG News
- 4 weeks ago - Novo Nordisk is losing Canadian patent protection on a blockbuster drug after not paying a small fee - Fortune
- 4 weeks ago - Ozempic Patent Expires In Canada After Novo Nordisk Fails To Pay $450 Fee: 'It's The Second-Largest Semaglutide Market In The World,' Says Sandoz CEO Richard Saynor - Benzinga
- 2 months ago - Sandoz Group AG (SDZNY) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Sandoz inks agreement with Shanghai Henlius for Bristol Yervoy biosimilar - Seeking Alpha
- 3 months ago - Sandoz Files Lawsuit Alleging Amgen Illegally Blocked Biosimilar Competition For Its Blockbuster Arthritis Drug - Benzinga
- 3 months ago - Amgen faces antitrust lawsuit from Sandoz over Enbrel patents - Seeking Alpha
- 3 months ago - Sandoz files antitrust litigation against Amgen regarding patient access to etanercept ... - GuruFocus
- 3 months ago - Novartis After Sandoz: The Business Without Generics - Seeking Alpha